Nicholson Wealth Management Group LLC Invests $574,000 in The Clorox Company (NYSE:CLX)

Nicholson Wealth Management Group LLC bought a new position in shares of The Clorox Company (NYSE:CLX) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,521 shares of the company’s stock, valued at approximately $574,000.

Several other large investors have also recently bought and sold shares of the stock. Innealta Capital LLC acquired a new position in shares of Clorox during the second quarter valued at about $30,000. Trifecta Capital Advisors LLC raised its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. GoalVest Advisory LLC bought a new stake in shares of Clorox in the 1st quarter worth approximately $31,000. First Foundation Advisors acquired a new stake in shares of Clorox during the 1st quarter worth approximately $31,000. Finally, Family Firm Inc. bought a new stake in shares of Clorox during the second quarter valued at approximately $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.51% of the stock is owned by company insiders.

Clorox Stock Performance

Clorox stock opened at $158.92 on Friday. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09. The stock has a 50-day simple moving average of $160.25 and a 200 day simple moving average of $145.43. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock has a market capitalization of $19.74 billion, a price-to-earnings ratio of 82.34, a P/E/G ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, research analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Analyst Ratings Changes

CLX has been the subject of several research reports. Citigroup raised their target price on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. TD Cowen assumed coverage on shares of Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $150.14.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.